Norda ASA Stock Oslo Bors
Equities
NORD
NO0010285190
Biotechnology & Medical Research
Sales 2021 | 139M 12.79M | Sales 2022 | 128M 11.74M | Capitalization | 204M 18.7M |
---|---|---|---|---|---|
Net income 2021 | 82M 7.53M | Net income 2022 | 100M 9.18M | EV / Sales 2021 | 0.22 x |
Net cash position 2021 | 159M 14.57M | Net cash position 2022 | 257M 23.56M | EV / Sales 2022 | -0.41 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-
| Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 6.26% |
Managers | Title | Age | Since |
---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 13-04-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-06-19 | |
Chairman | 52 | 12-06-20 | |
Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
-18.16% | 11.13B | |
+58.43% | 3.6B | |
-31.31% | 2.26B | |
-14.31% | 2.16B | |
-26.61% | 1.54B | |
+34.35% | 1.17B | |
-3.28% | 744M | |
-22.75% | 482M | |
-40.20% | 432M |